Prognostic value of a combination of cardiac biomarkers and risk indices for major adverse cardiovascular events following non-cardiac surgery in geriatric patients: a prospective cohort study
Open Access
- 17 April 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Abstract
Major adverse cardiovascular events (MACEs) in geriatric patients are an important cause of increased mortality and morbidity. The results of current studies regarding the predictive value of the NT-proBNP, H-FABP, and AUB-HAS2 scales for cardiovascular complications are inconsistent, and there is no relevant large sample study. Therefore, this study aimed to investigate whether preoperative NT-proBNP, H-FABP, and AUB-HAS2 alone or in combination can effectively predict postoperative cardiovascular complications in geriatric patients. A total of 1736 geriatric patients (aged ≥ 65 years) who were scheduled for elective non-cardiac surgery under general anesthesia were enrolled. AUB-HAS2 risk assessment is required for each patient, and blood was collected 1 h before surgery for the measurement of NT-proBNP and H-FABP. The primary outcomes were MACEs within 30 days after surgery. The secondary outcomes were other complications. Its predictive value was analyzed by receiver operating characteristic (ROC) curves. Of the 1736 patients, 71 (4.1%) had MACEs. NT-proBNP was a predictor of MACEs (AUC = 0.763; 95% CI 0.695–0.832; P < 0.001). When H-FABP was combined with AUB-HAS2, AUB-HAS2 increased the predictive value of H-FABP (AUC = 0.736; 95% CI 0.673–0.799; P < 0.001). Multiple logistic regression analysis revealed increased predictive value of the modified AUB-HAS2 scale for MACEs (AUC = 0.794, 95% CI = 0.737–0.851, P < 0.001). Our study revealed the predictive efficacy and prognostic value of NT-proBNP, H-FABP and the AUB-HAS2 score alone or in combination for postoperative MACE risk assessment in geriatric patients undergoing non-cardiac surgery. This trial was registered at the Chinese Clinical Trial Registry (2019/09/27 ChiCTR1900026223, https://www.chictr.org.cn).Keywords
Funding Information
- the Postdoctoral Researcher Fund of West China Hospital (2023HXBH131)
- The National Natural Science Foundation of China (82371280)
- 135 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC21008)
- Sichuan Natural Science Foundation Project (2023NSFSC1647)
This publication has 35 references indexed in Scilit:
- Risk of cardiovascular complications during non-cardiac surgery and preoperative cardiac evaluationTrends in Cardiovascular Medicine, 2022
- Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac SurgeryJAMA Cardiology, 2017
- Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart FailureJACC, 2016
- Validation of High-Sensitivity Troponin I in a 2-Hour Diagnostic Strategy to Assess 30-Day Outcomes in Emergency Department Patients With Possible Acute Coronary SyndromeJACC, 2013
- Analytic comments of the initial results of the VISION (Vascular events In noncardiac Surgery patIents cOhort evaluatioN): Association between troponin T and mortality at 30 days in noncardiac surgery patientsRevista Española de Anestesiología y Reanimación, 2013
- Third Universal Definition of Myocardial InfarctionGlobal Heart, 2012
- Is a Pre-Operative Brain Natriuretic Peptide or N-Terminal Pro–B-Type Natriuretic Peptide Measurement an Independent Predictor of Adverse Cardiovascular Outcomes Within 30 Days of Noncardiac Surgery?JACC, 2009
- The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphismJournal of Applied Genetics, 2006
- Fatty acid-binding proteins as plasma markers of tissue injuryClinica Chimica Acta, 2005
- Value of N-Terminal Pro Brain Natriuretic Peptide in the Elderly: Data from the Prospective Copenhagen Hospital Heart Failure Study (CHHF)European Journal of Heart Failure, 2004